budesonide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI
AUST R: 339070
Active ingredients:
budesonide
formoterol fumarate dihydrate
glycopyrronium bromide

Dosage form:
Inhalation, pressurised

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

Deletion from market:
16 Oct 2023

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative product by same sponsor available - BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI (DFP-EvoCap) ARTG 386646

SYMBICORT RAPIHALER budesonide / formoterol fumarate dihydrate 50/3 pressurised metered dose inhaler
AUST R: 158898
Active ingredients:
budesonide
formoterol fumarate dihydrate

Dosage form:
Inhalation, pressurised

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

Deletion from market:
31 Aug 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability